Ex vivo drug susceptibility testing and molecular profiling of clinical Plasmodium falciparum isolates from Cambodia from 2008 to 2013 suggest emerging piperaquine resistance

Suwanna Chaorattanakawee, David L. Saunders, Darapiseth Sea, Nitima Chanarat, Kritsanai Yingyuen, Siratchana Sundrakes, Piyaporn Saingam, Nillawan Buathong, Sabaithip Sriwichai, Soklyda Chann, Youry Se, You Yom, Thay Kheng Heng, Nareth Kong, Worachet Kuntawunginn, Kuntida Tangthongchaiwiriya, Christopher Jacob, Shannon Takala-Harrison, Christopher Plowe, Jessica T. LinChar Meng Chuor, Satharath Prom, Stuart D. Tyner, Panita Gosi, Paktiya Teja-Isavadharm, Chanthap Lon, Charlotte A. Lanteri*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Ex vivo drug susceptibility testing and molecular profiling of clinical Plasmodium falciparum isolates from Cambodia from 2008 to 2013 suggest emerging piperaquine resistance'. Together they form a unique fingerprint.

Medicine & Life Sciences